Wednesday, September 16, 2026Latest filing Sep 14, 2026

Sheldon Whitehouse Periodic Transaction Report

Filed May 4, 2026 · Senate eFD · 1 transaction

U.S. Senator · D · RI · All trades by Sheldon Whitehouse

On May 4, 2026, Sen. Sheldon Whitehouse (D-RI) filed a periodic transaction report with the Senate eFD disclosing 1 transaction (1 sale) dated Apr 13, 2026.

The filing covers 1 ticker, including $JPM.

Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 21 days.

Source document: Senate eFD filing 747b4aac-bbc9-4636-bf0f-95b0454e39d9

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Sheldon Whitehouse · Sold $JPM · Apr 13 · $15K–$50K

0.42LOW
Disclosure speedx 0.250.30
Trade sizex 0.250.50
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Sheldon Whitehouse

Get an email the moment Sheldon Whitehouse files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sells
1
Tickers
21d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Apr 13, 2026JPMJP Morgan Chase & Co. Common StocksellSelf$15K–$50K21d

Other recent filings by Sheldon Whitehouse

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →